Our Research: Equity in Discovery and Innovation


Leaders in Equal Access to Research Innovation

As world leaders in cancer research discovery and innovation, Dana-Farber is ever mindful that our breakthrough research — and the innovative care that results from that research — needs to be equally accessible to all patient populations, regardless of race, socioeconomics, gender, identity, veteran status, or other differentiators.

This is why, at Dana-Farber, we are deeply committed to:

  • Growing our research in cancer disparities
  • Increasing minority representation in clinical trials
  • Integrating our research findings into clinical care and public health

Some of Our Cancer Disparities Research Initiatives


Cancer Care Equity Program

This program places Dana-Farber at the forefront of efforts to reduce disparities in cancer outcomes for historically marginalized groups locally — and has become a national model for translating cancer equity research into interventions.


Center for Cancer Equity and Engagement

This center works to ensure that the work and research of the Dana-Farber/Harvard Cancer Center reduces the cancer burden and inequity for all Massachusetts residents.



This study seeks to identify people with precursor conditions for multiple myeloma. African Americans are three times more likely than Caucasians to develop these conditions.